Effects of intranasally-delivered pro-nerve growth factors on the septo-hippocampal system in healthy and diabetic rats.
Administration, Intranasal
Animals
Diabetes Mellitus, Experimental
/ metabolism
Drug Delivery Systems
/ methods
Female
Hippocampus
/ drug effects
Mice
Nerve Growth Factor
/ administration & dosage
Nerve Net
/ drug effects
Organ Culture Techniques
Protein Precursors
/ administration & dosage
Rats
Rats, Sprague-Dawley
Septum of Brain
/ drug effects
Cholinergic system
Dentate-gyrus long-term potentiation (DG-LTP)
Diabetes
Hippocampal neurogenesis
Rat
pro nerve growth factor (proNGF)
Journal
Neuropharmacology
ISSN: 1873-7064
Titre abrégé: Neuropharmacology
Pays: England
ID NLM: 0236217
Informations de publication
Date de publication:
01 10 2020
01 10 2020
Historique:
received:
01
04
2020
revised:
22
06
2020
accepted:
25
06
2020
pubmed:
19
7
2020
medline:
14
8
2021
entrez:
19
7
2020
Statut:
ppublish
Résumé
Pro-nerve growth factor (proNGF) is the predominant form of NGF in the brain and its levels increase in neurodegenerative diseases. The balance between NGF receptors may explain the contradictory biological activities of proNGF. However, the specific role of the two main proNGF variants is mostly unexplored. proNGF-A is prevalently expressed in healthy brain, while proNGF-B content increases in the neuro-degenerating brain. Recently we have investigated in vitro the biological action of native mouse proNGF variants. To gain further insights into the specific functions of the two proNGFs, here we intranasally delivered mouse-derived proNGF-A and proNGF-B to the brain parenchyma of healthy and diabetic rats, the latter characterized by dysfunction in spatial learning and memory, in the septo-hippocampal circuitry and by relative increase in proNGF-B hippocampal levels. Exogenous proNGF-B induces depression of hippocampal DG-LTP and impairment of hippocampal neurogenesis in healthy animals, with concomitant decrease in basal forebrain cholinergic neurons and cholinergic fibers projecting to the hippocampus. proNGF-A, while ineffective in healthy animals, rescues the diabetes-induced impairment in DG-LTP and hippocampal neurogenesis, promoting the concomitant recovery of the basal forebrain cholinergic phenotype. Our experimental evidences suggest that the balance between different proNGFs may influence the development and progression of neurodegenerative diseases.
Identifiants
pubmed: 32681844
pii: S0028-3908(20)30291-4
doi: 10.1016/j.neuropharm.2020.108223
pii:
doi:
Substances chimiques
Protein Precursors
0
pro-nerve growth factor, mouse
0
Nerve Growth Factor
9061-61-4
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
108223Informations de copyright
Copyright © 2020 Elsevier Ltd. All rights reserved.